35 years Cooperative Weichteilsarkom Studiengruppe CWS

December 16th, 2016:
Soft Tissue Sarcoma in the Young: Expectations, Achievements and Perspectives

Dear Colleagues,

2016 witnesses the 35th anniversary of the CWS Study Group. On December 16th, CWS along with the EpSSG and STS COG study groups will take stock of what has been achieved in soft tissue sarcoma and what the next study priorities should be. We therefore cordially invite you to the international symposium “Soft Tissue Sarcoma  in the Young: Expectation, Achievements and Perspectives“, to be held in Stuttgart, Germany. Very renowned international speakers from both sides of the Atlantic have confirmed their participation and we believe you will agree that the program has lots to offer for anyone with an interest in sarcoma.

We are very much looking forward to welcoming you to Stuttgart this December!

Prof. Dr. E. Koscielniak, Stuttgart
Prof. Dr. T. Klingebiel, Frankfurt
Prof. Dr. S. Bielack, Stuttgart

Contact

Stuttgart Cancer Center (SCC) –
Tumorzentrum Eva Mayr-Stihl
Dr. Sabine Gebhardt
Kriegsbergstr. 60
70174 Stuttgart
Phone: 0049 711 278 30404
Fax: 0049 711 278 30405
scc-geschaeftsstelle@klinikum-stuttgart.de

Online-Registration

Please click here for online registration

Receive the congress flyer as pdf here

Venue: Linden-Museum, Wannersaal, Hegelstr. 1, 70174 Stuttgart, Germany

Arrival by car

Motorways

  • A 8: Karlsruhe – Stuttgart – Munich (Exits Stuttgart-Zentrum / Vaihingen, Stuttgart-Degerloch, Stuttgart-Flughafen)
  • A 81:Stuttgart – Heilbronn – Würzburg (Exits Stuttgart-Feuerbach, Stuttgart-Zuffenhausen)
  • A 831 / A81: Stuttgart – Rottweil – Singen – Lake Constance (Exit Stuttgart-Zentrum / Vaihingen)

National roads

  • B 10
  • B 14
  • B 27
  • B 295

Follow the signs to City Center / Main Station. From the Main Station follow Kriegsbergstraße to Hegelplatz with the Linden-Museum on the right.

The Linden-Museum has no parking facilities, but the car parks Olgahospital (Keplerstraße), Stadtgarten (Kriegsbergstraße) and Liederhalle (Holzgartenstraße) are only a few minutes’ walk from the museum.

Arrival by train

Stuttgart Main Station is at the junction of the international north-south and east-west train routes. Through the rail network (ICE, IC; InterRegio), Stuttgart is directly connected with 13 European capitals.

From Stuttgart Main Station it is a ten-minutes’ walk to Linden-Museum. You can also take bus no. 40 (direction Vogelsang) and no. 42 (direction Erwin-Schoettle-Platz) to bus-stop “Linden-Museum / Olgahospital”.

Arrival by plane

The S Bahn leaves from Terminal 1, taking you directly to the city center and the Main Station in ca. 25 minutes. At Stuttgart Airport you can also find taxis, car rental companies and busses.

By car Stuttgart city center can be reached via the motorway A8 and the B27. The motorway A8 directly passes by the Airport.

Scientific Program

9:45 a.m. Welcoming remarks S. Bielack, E. Koscielniak


1. Global Achievements and Perspectives   10:00 a.m.-12 noon
Chairs: G. Bisogno, E. Koscielniak

  • 10:10 a.m.
    Treating pediatric soft tissue sarcomas in the genomic and targeted therapy age: the Children’s Oncology Group approach. D. Hawkins
  • 10:40 a.m.
    The more things change, the more they remain the same, or do they? Chemotherapy in RMS. C. Arndt
  • 11:10 a.m.
    “FaR-RMS” – the next EpSSG study in newly diagnosed and relapsed RMS. J. Chisholm
  • 11:40 a.m.
    Metastatic soft tissue sarcoma in children and adolescents: More or less? T. Klingebiel

Break 12 noon-12:30 p.m.


2. Soft tissue sarcoma in young and old    12:30-1:20 p.m.
Chairs: C. Arndt, S. Bielack

  • 12:30 p.m.
    How to proceed to improve prognosis for the NRSTS. EpSSG view. A. Ferrari
  • 12:50 p.m.
    EuroJoss European Synovial Sarcoma Joint Study D. Orbach
  • 1:05 p.m.
    High risk synovial sarcoma. CWS results. M. Scheer
  • 1:15 p.m.
    How to proceed for better AYA care? Improving infrastructure and outcomes for adolescents and young adults. S. Bielack

Lunch 13:30-14:30


3. Pathology and molecular biology    2:30-3:45 p.m.
Chairs: D. Hawkins, S. Hettmer

  • 2.30 p.m.
    Do we need a new rhabdomyosarcoma classification? I. Leuschner
  • 2.45 p.m.
    Cellular origins of rhabdomyosarcoma: recent insights, new perspectives and clinical implications. S. Hettmer 
  • 3:00 p.m.
    Harnessing PAX3-FOXO1 biology to develop novel combination treatments in rhabdomyosarcoma. B. Schäfer
  • 3:15 p.m.
    Perspectives for molecular based therapy in pediatric soft tissue sarcoma. S. Fulda
  • 3.30 p.m.
    Individualized therapy for relapsed malignancies in childhood (INFORM). Update on soft tissue sarcoma patients. M. Meister

Break 3:45-4:00 p.m.


4. Surgery and irradiation     4:00-5:00 p.m.
Chairs: G. Seitz, A. Ferrari

  • 4:00 p.m.
    Defining the role of radiotherapy for RMS: Current EpSSG strategy and future questions. 
    H. C. Mandeville
  • 4:15 p.m.
    Irradiation in children with soft tissue sarcoma: escalate or de-escalate? M. Münter
  • 4:30 p.m.
    Primary surgical approach. Does it influence prognosis? S. Loff
  • 4:45 p.m.
    The role of delayed surgery in patients with rhabdomyosarcoma. J. Fuchs 

5. Future perspectives     5:00-5:20 p.m.

  • 5:00 p.m.
    Quo vadis international cooperation: more or less. CWS view. E. Koscielniak 
    Concluding remarks. T. Klingebiel, S. Bielack

Invited Speakers and Chairs

  • Carola Arndt, MD
    Member of the Soft Tissue Sarcoma Committee of Children`s Oncology Group
    Mayo Clinic Rochester
    200 1st St SW,
    Rochester, MN 55905, USA
  • Stefan Bielack, Prof. Dr.
    Direktor, Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)
    Klinikum Stuttgart - Olgahospital
    Zentrum für Kinder-, Jugend- und Frauenmedizin
    Kriegsbergstr. 62
    70174 Stuttgart, GERMANY
  • Gianni Bisogno, MD
    Board EpSSG, Chairman
    Head of the Solid Tumour Unit, Division of Haematology / Oncology, Department of Woman’s and Child’s Health, University Hospital of Padova
    Via Giustiniani 3
    35128 Padova, ITALY
  • Julia Chisholm, MD
    Consultant Paediatric Oncologist
    Team Leader in Sarcoma Clinical Trials in Children and Young People at the Institute of Cancer Research
    The Royal Marsden Hospital (Surrey)
    020 8642 6011 Downs Road
    Sutton, Surrey, SM2 5PT, UK
  • Andrea Ferrari, MD
    Chair NRSTS Protocol EpSSG
    Fundazione IRCCS
    Istituto Nazionale dei Tumori
    Via Venezian 1
    20133 Milano, ITALY
  • Jörg Fuchs, Prof. Dr.
    Direktor, Abteilung für Kinderchirurgie und Kinderurologie,
    Universitätsklinik für Kinder- und Jugendmedizin,
    Hoppe-Seyler-Str. 3
    72076 Tübingen, GERMANY
  • Simone Fulda, Prof. Dr.
    Direktorin, Institut für Experimentelle Tumorforschung in der Pädiatrie
    Goethe-Universität Frankfurt, Fachbereich Medizin
    Komturstr. 3a
    60528 Frankfurt, GERMANY
  • Douglas S Hawkins, MD
    Chair of the Soft Tissue Sarcoma Committee of Children`s Oncology Group
    Seattle Children's Hospital
    MB.8.501 - Hematology-Oncology
    4800 Sand Point Way NE
    Seattle, WA 98105, USA
  • Simone Hettmer, PD Dr.
    Zentrum für Kinder- und Jugendmedizin
    Universitätsklinikum Freiburg, Klinik IV: Pädiatrische Haematologie und Onkologie
    Mathildenstr. 1
    79106 Freiburg, GERMANY
  • Thomas Klingebiel, Prof. Dr.
    Chair of the Cooperative Weichteilsarkom Studiengruppe
    Direktor, Klinik für Kinder und Jugendmedizin
    Goethe-Universität Frankfurt, Fachbereich Medizin
    Theodor Stern Kai 7
    60590 Frankfurt, GERMANY
  • Ewa Koscielniak, Prof. Dr. 
    Chair of the Cooperative Weichteilsarkom Studiengruppe
    Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)
    Klinikum Stuttgart - Olgahospital
    Zentrum für Kinder-, Jugend- und Frauenmedizin
    Kriegsbergstr. 62
    70174 Stuttgart, GERMANY
  • Ivo Leuschner, Prof. Dr.
    Kindertumorregister der GPOH
    Stellv. Direktor des Instituts für Pathologie
    Universitätsklinikum Schleswig-Holstein
    Michaelisstr. 11
    24105 Kiel, GERMANY
  • Steffan Loff, Prof. Dr.
    Direktor, Klinik für Kinderchirurgie
    Klinikum Stuttgart - Olgahospital
    Zentrum für Kinder-, Jugend- und Frauenmedizin
    Kriegsbergstr. 62
    70174 Stuttgart, GERMANY
  • Henry C. Mandeville, MD
    Radiotherapy Committee Chair of the EpSSG
    Consultant Clinical Oncologist
    Children's & Young Person's Unit & Haemato-oncology Unit
    The Royal Marsden
    NHS Foundation Trust
    Sutton, UK
  • Michael Meister, Dr.
    Frankfurter Stiftung für krebskranke Kinder
    Institut für Experimentelle Tumorforschung in der Pädiatrie
    Goethe-Universität Frankfurt, Fachbereich Medizin
    Komturstr. 3a
    60528 Frankfurt, GERMANY
  • Marc Münter, Prof. Dr.
    Direktor, Radioonkologie und Strahlentherapie/MVZ-Katharinenhospital
    Klinikum Stuttgart
    Zentrum für Kinder-, Jugend- und Frauenmedizin
    Kriegsbergstr. 60
    70174 Stuttgart, GERMANY
  • Daniel Orbach, MD
    Consultant Paediatric Oncologist
    Département d'oncologie pédiatrique
    CLCC Institut Curie
    26 rue d'Ulm
    75248 Paris CEDEX 05, FRANCE
  • Beat Schäfer, Prof. Dr.
    Forschungszentrum für das Kind FZK,
    Universitäts-Kinderspital Zürich, Eleonorenstiftung
    Steinwiesstr. 75
    8032 Zürich, SWITZERLAND
  • Monika Scheer, Dr.
    Member of the Cooperative Weichteilsarkom Studiengruppe  
    Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)
    Klinikum Stuttgart - Olgahospital
    Zentrum für Kinder-, Jugend- und Frauenmedizin
    Kriegsbergstr. 62
    70174 Stuttgart, GERMANY
  • Guido Seitz, Prof. Dr.
    Ärztlicher Direktor
    Lehrstuhl und Klinik für Kinderchirurgie
    Universitätsklinikum Marburg
    Baldingerstraße
    35043 Marburg, GERMANY

Accomodation

Hotels near Linden-Museum

Certification

Points for continuing medical education have been requested at the Ärztekammer Baden-Württemberg.

Participating Companies

We are grateful for the financial support of participating companies.

  • Lilly Deutschland GmbH   1.500 €
  • Takeda Pharma Vertriebs GmbH & Co. KG   1.000 €
  • Pharma Mar S.A.   750 €
  • MSD Sharp & Dohme GmbH   750 €
  • Gilead Sciences GmbH   500 €
  • Novartis Pharma GmbH   500 €
  • Jazz Pharmceuticals GmbH   300 €

In return, the opportunity for advertising is provided.